CIDRAP newsletters options
A study today in Nature Medicine showed Pfizer's mRNA vaccine, the first vaccine approved in the United States for use against COVID-19, neutralized three variants of the virus, including the B117 strain first identified in the United Kingdom, and two new variants first confirmed in South Africa.
For men with COVID-19, the risk of dying from an out-of-hospital cardiac arrest rose 4.5-fold.
In light of the request, FDA advisors will meet on Feb 26 to weigh emergency use.
The global number of people vaccinated has now eclipsed the number infected.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A multifaceted intervention implemented in a Japanese emergency department was associated with reduced antibiotic prescribing at discharge and an increase in appropriate prescribing, Japanese researchers reported today in Infection Control and Hospital Epidemiology.
A randomized control trial shows that being exposed to misinformation about the COVID-19 vaccine induced a decline in the intent to definitely get the COVID vaccine of 6.2 percentage points in the United Kingdom and 6.4 percentage points in the United States, according to a study today in Nature Human Behaviour.
Though per capita antibiotic use in LMICs is lower than in wealthier nations, rates are converging.
States continue to struggle with how best to reach the elderly and minorities, groups at greater risk for severe COVID-19.
Patients on long-term dialysis were also more than 5 times likelier to be infected.
Also, a UK group adds more evidence that the B117 variant is about a third deadlier.
An international team of researchers has identified a new and always lethal neurologic disease in chimpanzees living in a sanctuary in Sierra Leone. The scientists, including researchers from the University of Wisconsin-Madison, reported their findings yesterday in Nature Communications.
Except for a slight decrease from Mar 29 to Apr 11, 2020, emergency department (ED) visits involving drug and opioid overdoses (ODs) were 1% to 45% more frequent than in 2019, according to a JAMA Psychiatry study published yesterday.
Though US numbers have fallen, the CDC head warns they are overall still very high.
People age 35 to 49 have especially contributed to recent outbreaks.
Findings suggest the vaccine provides strong protection after 1 dose and could slow disease spread.
Higher viral loads of SARS-CoV-2, the virus that causes COVID-19, are associated with an increased risk of transmission, according to cohort study results from Catalonia, Spain, published yesterday in The Lancet Infectious Diseases,
CARB-X announced today that it is awarding up to $6.4 million to French biopharmaceutical firm Mutabilis to develop a new class of antibiotics to treat infections caused by carbapenem-resistant Enterobacterales (CRE) bacteria.
Also, vaccine doses sent to states will rise from 10 million to 10.5 million.
CDC researchers recommend improving racial data tracking and health workers' uptake.
